Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Other Operating Expenses (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Other Operating Expenses for 4 consecutive years, with -$5.4 million as the latest value for Q4 2018.

  • Quarterly Other Operating Expenses changed N/A to -$5.4 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$15.4 million through Dec 2018, down 408.81% year-over-year, with the annual reading at -$2.1 million for FY2025, 74.54% up from the prior year.
  • Other Operating Expenses hit -$5.4 million in Q4 2018 for Armata Pharmaceuticals, down from -$4.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.8 million in Q2 2017 to a low of -$5.9 million in Q2 2018.
  • Historically, Other Operating Expenses has averaged -$233777.8 across 4 years, with a median of $24000.0 in 2014.
  • Biggest five-year swings in Other Operating Expenses: tumbled 151.36% in 2017 and later plummeted 388.06% in 2018.
  • Year by year, Other Operating Expenses stood at $24000.0 in 2014, then soared by 19891.67% to $4.8 million in 2016, then crashed by 117.28% to -$829000.0 in 2017, then plummeted by 553.8% to -$5.4 million in 2018.
  • Business Quant data shows Other Operating Expenses for ARMP at -$5.4 million in Q4 2018, -$4.0 million in Q3 2018, and -$5.9 million in Q2 2018.